Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Aerie Pharmaceuticals stock
Own Aerie Pharmaceuticals stock in just a few minutes.
Aerie Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. Aerie Pharmaceuticals shares (AERI) are listed on the NASDAQ and all prices are listed in US Dollars. Aerie Pharmaceuticals employs 365 staff and has a trailing 12-month revenue of around USD$83.1 million.
How to buy shares in Aerie Pharmaceuticals
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Aerie Pharmaceuticals. Find the stock by name or ticker symbol: AERI. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aerie Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Aerie Pharmaceuticals, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Aerie Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Aerie Pharmaceuticals share price
Use our graph to track the performance of AERI stocks over time.Aerie Pharmaceuticals shares at a glance
Information last updated 2021-04-08.
| 52-week range | USD$9.01 - USD$21.3 |
|---|---|
| 50-day moving average | USD$18.4321 |
| 200-day moving average | USD$14.5304 |
| Wall St. target price | USD$27.25 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-5.169 |
Buy Aerie Pharmaceuticals shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Aerie Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aerie Pharmaceuticals financials
| Revenue TTM | USD$83.1 million |
|---|---|
| Gross profit TTM | USD$55.5 million |
| Return on assets TTM | -22.77% |
| Return on equity TTM | -191.81% |
| Profit margin | -220.24% |
| Book value | $0.512 |
| Market capitalisation | USD$846.4 million |
TTM: trailing 12 months
Shorting Aerie Pharmaceuticals shares
There are currently 7.1 million Aerie Pharmaceuticals shares held short by investors – that's known as Aerie Pharmaceuticals's "short interest". This figure is 3.6% down from 7.3 million last month.
There are a few different ways that this level of interest in shorting Aerie Pharmaceuticals shares can be evaluated.
Aerie Pharmaceuticals's "short interest ratio" (SIR)
Aerie Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Aerie Pharmaceuticals shares currently shorted divided by the average quantity of Aerie Pharmaceuticals shares traded daily (recently around 714065.99190283). Aerie Pharmaceuticals's SIR currently stands at 9.88. In other words for every 100,000 Aerie Pharmaceuticals shares traded daily on the market, roughly 9880 shares are currently held short.
However Aerie Pharmaceuticals's short interest can also be evaluated against the total number of Aerie Pharmaceuticals shares, or, against the total number of tradable Aerie Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aerie Pharmaceuticals's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Aerie Pharmaceuticals shares in existence, roughly 150 shares are currently held short) or 0.2067% of the tradable shares (for every 100,000 tradable Aerie Pharmaceuticals shares, roughly 207 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Aerie Pharmaceuticals.
Find out more about how you can short Aerie Pharmaceuticals stock.
Aerie Pharmaceuticals share dividends
We're not expecting Aerie Pharmaceuticals to pay a dividend over the next 12 months.
Aerie Pharmaceuticals share price volatility
Over the last 12 months, Aerie Pharmaceuticals's shares have ranged in value from as little as $9.01 up to $21.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aerie Pharmaceuticals's is 0.7248. This would suggest that Aerie Pharmaceuticals's shares are less volatile than average (for this exchange).
Aerie Pharmaceuticals overview
Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, ocular surface, and retinal diseases in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma. The company is also developing AR-15512 to treat signs and symptoms of dry eye; and AR-1105, AR-13503 SR, and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert